Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 700K - 700K
Notice Type:
Contract Notice
Published Date:
04 October 2021
Closing Date:
01 November 2021
Location(s):
FI SUOMI / FINLAND (FI Finland/SUOMI / FINLAND)
Description:
Adrenaline (autoinjectors), posaconazole, bortezomib and fulvestrant medicinal products for the period 1.1.2022-31.12.2022

Purchase of adrenaline (autoinjectors; C01CA24), posaconazole (J02AC04), bortezomib (L01XG01) and fulvestrant (L02BA03) medicinal products for the period 1.2022-31.12.2022. The acquisition applies to marketable medicinal products for people in Finland, which are marketed in Finland on 1.1.2022.

Purchase of adrenaline (autoinjectors; C01CA24), posaconazole (J02AC04), bortezomib (L01XG01) and fulvestrant (L02BA03) medicinal products for the period 1.2022-31.12.2022. The acquisition applies to marketable medicinal products for people in Finland, which are marketed in Finland on 1.1.2022.

Download full details as .pdf
The Buyer:
Pohjois-Pohjanmaan sairaanhoitopiirin kuntayhtymä
CPV Code(s):
33600000 - Pharmaceutical products